04:43 AM EST, 11/17/2025 (MT Newswires) -- Mesoblast (MESO) said Monday it has appointed James O'Brien as its chief financial officer.
O'Brien previously worked at different pharmaceutical companies, including Bristol-Myers Squibb (BMY) and Cognition Therapeutics (CGTX), the company said.